Skip to main content
. 2023 Dec 1;27(1):44. doi: 10.3892/etm.2023.12332

Figure 3.

Figure 3

Changes in NLRP3 inflammasome components upon emodin treatment. (A-D) Representative immunofluorescence staining images and quantitative analysis of spinal NLRP3 and caspase-1 in the control, CFA and CFA + emodin groups. Scale bar, 20 µm. (E) Representative western blots and (F) quantitation examination of NLRP3 and cleaved caspase-1 expression levels the in spinal cords of the control, CFA and CFA + emodin groups. Data are presented as the mean ± SD (n=5). *P<0.05 vs. control group, #P<0.05 vs. CFA group. NLRP3, Nod-like receptor family pyrin domain-containing 3; CFA, complete Freund's adjuvant.